Cordova Ashley
Former Chief Executive Officer
Cordova Ashley has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Cordova Ashley is listed as Chief Executive Officer at NovoCure Ltd. Inside the rolling window, Cordova Ashley reported 1 open-market purchase totaling $997K in NVCR and no open-market sales.
Companies traded
Other insiders at NVCR
Insider Buying
$997K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cordova Ashley made?
Cordova Ashley has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Cordova Ashley trade?
Cordova Ashley has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Cordova Ashley's most recent SEC Form 4 filing?
Cordova Ashley's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Cordova Ashley's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cordova Ashley is listed as Former Chief Executive Officer.
What is Cordova Ashley's total buy and sell value in the current window?
Inside the rolling retention window, Cordova Ashley bought $997K and sold $0 based on SEC Form 4 filings.
What was Cordova Ashley's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 81,550 NVCR shares on 2025-09-05, worth $997K, per SEC Form 4 filings.